19-15238836-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001379291.1(BRD4):c.3927C>T(p.Thr1309=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000767 in 1,603,344 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0039 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00044 ( 13 hom. )
Consequence
BRD4
NM_001379291.1 synonymous
NM_001379291.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.184
Genes affected
BRD4 (HGNC:13575): (bromodomain containing 4) The protein encoded by this gene is homologous to the murine protein MCAP, which associates with chromosomes during mitosis, and to the human RING3 protein, a serine/threonine kinase. Each of these proteins contains two bromodomains, a conserved sequence motif which may be involved in chromatin targeting. This gene has been implicated as the chromosome 19 target of translocation t(15;19)(q13;p13.1), which defines an upper respiratory tract carcinoma in young people. Two alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 19-15238836-G-A is Benign according to our data. Variant chr19-15238836-G-A is described in ClinVar as [Benign]. Clinvar id is 710756.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.184 with no splicing effect.
BS2
High AC in GnomAd4 at 589 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRD4 | NM_001379291.1 | c.3927C>T | p.Thr1309= | synonymous_variant | 19/20 | ENST00000679869.1 | NP_001366220.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRD4 | ENST00000679869.1 | c.3927C>T | p.Thr1309= | synonymous_variant | 19/20 | NM_001379291.1 | ENSP00000506350 | P1 | ||
BRD4 | ENST00000263377.6 | c.3927C>T | p.Thr1309= | synonymous_variant | 19/20 | 1 | ENSP00000263377 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00384 AC: 585AN: 152234Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
585
AN:
152234
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000941 AC: 215AN: 228568Hom.: 4 AF XY: 0.000678 AC XY: 85AN XY: 125320
GnomAD3 exomes
AF:
AC:
215
AN:
228568
Hom.:
AF XY:
AC XY:
85
AN XY:
125320
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000441 AC: 640AN: 1450992Hom.: 13 Cov.: 32 AF XY: 0.000361 AC XY: 260AN XY: 720608
GnomAD4 exome
AF:
AC:
640
AN:
1450992
Hom.:
Cov.:
32
AF XY:
AC XY:
260
AN XY:
720608
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00387 AC: 589AN: 152352Hom.: 6 Cov.: 32 AF XY: 0.00366 AC XY: 273AN XY: 74496
GnomAD4 genome
AF:
AC:
589
AN:
152352
Hom.:
Cov.:
32
AF XY:
AC XY:
273
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
BRD4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 08, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at